Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income (loss) attributable to Flotek Industries, Inc. (Flotek)	$ (11,110,000)	$ 7,284,000	$ (78,899,000)
Less: Income from discontinued operations, net of tax	117,000	46,881,000	4,176,000
Loss from continuing operations	(11,227,000)	(39,597,000)	(83,075,000)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	2,058,000	6,437,000	6,935,000
Amortization of deferred financing costs	0	1,428,000	294,000
Provision for doubtful accounts		426,000	176,000
Provision for excess and obsolete inventory		0	1,817,000
Impairment of goodwill	0	0	37,180,000
Loss on sale of business	0	0	(360,000)
Loss on write-down of assets held for sale	0	0	2,580,000
Loss on disposal of long-lived assets		1,096,000	119,000
Non-cash lease expense		813,000
Stock compensation expense		2,829,000	6,594,000
Deferred income tax provision		17,983,000	15,358,000
Reduction in tax benefit related to share-based awards		24,000	312,000
Changes in current assets and liabilities:
Restricted cash		(663,000)	0
Accounts receivable, net		21,629,000	(10,392,000)
Inventories, net		3,000,000	(1,490,000)
Income taxes receivable		2,853,000	58,000
Other current assets		(14,974,000)	1,759,000
Accounts payable		(4,434,000)	5,672,000
Accrued liabilities		(13,122,000)	(9,001,000)
Income taxes payable		595,000	0
Interest payable		(8,000)	(37,000)
Net cash used in operating activities		(13,685,000)	(24,781,000)
Cash flows from investing activities:
Capital expenditures		(1,869,000)	(3,965,000)
Proceeds from sale of business		169,722,000	1,665,000
Proceeds from sale of assets		234,000	361,000
Purchase of patents and other intangible assets		(590,000)	(1,466,000)
Net cash (used in) provided by investing activities		167,497,000	(3,405,000)
Cash flows from financing activities:
Borrowings on revolving credit facility		42,984,000	213,612,000
Repayments on revolving credit facility		(92,715,000)	(188,160,000)
Debt issuance costs		0	(98,000)
Purchase of treasury stock related to share-based awards		(207,000)	(91,000)
Proceeds from sale of common stock		7,000	341,000
Payments for finance leases	6,000	51,000
Loss from noncontrolling interest		0	(357,000)
Net cash (used in) provided by financing activities		(49,880,000)	25,247,000
Discontinued operations:
Net cash (used in) provided by operating activities		(321,000)	880,000
Net cash (used in) provided by investing activities		337,000	(630,000)
Net cash flows provided by discontinued operations		16,000	250,000
Effect of changes in exchange rates on cash and cash equivalents		2,000	(66,000)
Net increase (decrease) in cash and cash equivalents		103,950,000	(2,755,000)
Cash and cash equivalents at the beginning of period		3,044,000	4,584,000
Cash and cash equivalents at the end of period	$ 106,994,000	$ 106,994,000	$ 1,829,000